| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4259236 | Transplantation Proceedings | 2009 | 5 Pages |
Abstract
CYP3A5 influenced the blood concentrations of tacrolimus. Our study suggested to choose the initial dosage according to the CYP3A5 genotype to obtain a better outcome and reduce the incidences of acute rejection episodes and nephrotoxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
J.S. Chen, L.S. Li, D.R. Cheng, S.M. Ji, Q.Q. Sun, Z. Cheng, J.Q. Wen, G.Z. Sha, Z.H. Liu,